Boster, J.M.; Goertzen, S.M.; Sainz, P.V.; Vial, M.R.; Zaveri-Desai, J.K.; Luna, L.D.; Waqar, A.; Grosu, H.B.; Casal, R.F.; Jimenez, C.A.;
et al. Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy. Diagnostics 2025, 15, 2136.
https://doi.org/10.3390/diagnostics15172136
AMA Style
Boster JM, Goertzen SM, Sainz PV, Vial MR, Zaveri-Desai JK, Luna LD, Waqar A, Grosu HB, Casal RF, Jimenez CA,
et al. Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy. Diagnostics. 2025; 15(17):2136.
https://doi.org/10.3390/diagnostics15172136
Chicago/Turabian Style
Boster, Joshua M., S. Michael Goertzen, Paula V. Sainz, Macarena R. Vial, Jhankruti K. Zaveri-Desai, Luis D. Luna, Anum Waqar, Horiana B. Grosu, Roberto F. Casal, Carlos A. Jimenez,
and et al. 2025. "Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy" Diagnostics 15, no. 17: 2136.
https://doi.org/10.3390/diagnostics15172136
APA Style
Boster, J. M., Goertzen, S. M., Sainz, P. V., Vial, M. R., Zaveri-Desai, J. K., Luna, L. D., Waqar, A., Grosu, H. B., Casal, R. F., Jimenez, C. A., Ost, D. E., Sabath, B. F., Lin, J., Hernandez, M., & Eapen, G. A.
(2025). Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy. Diagnostics, 15(17), 2136.
https://doi.org/10.3390/diagnostics15172136
